Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $194.16 USD
Change Today +1.06 / 0.55%
Volume 10.0K
As of 9:44 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John H. Weiland

President, Chief Operating Officer and Director, CR Bard Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 3 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. John H. Weiland has been Vice President and Secretary of Rochester Medical Corporation since November 14, 2013. Mr. Weiland has been the President and Chief Operating Officer of the CR Bard Inc. since August 8, 2003. Mr. Weiland served as the Group President of Davol, Urological, Medical and Endoscopic Technology at CR Bard Inc. since 1997 until August 2003 , where he has responsibility for all Bard's businesses in Japan, Latin and Central America, Canada and Asia ...

Read Full Background

Corporate Headquarters*

730 Central Avenue
Murray Hill, New Jersey 07974

United States

Phone: 908-277-8000
Fax: 908-277-8412

Board Members Memberships*

President, Chief Operating Officer and Director
Director and Chairman of Compensation Committee
Vice President, Secretary and Director


New York University
DeSales University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$887,000

Stock Options*

Restricted Stock Awards$2,398,137
All Other Compensation$1,011,689
Exercised Options194,124
Exercised Options Value$10,512,916
Exercisable Options33,524
Exercisable Options Value$1,879,833
Unexercisable Options101,427
Unexercisable Options Value$3,669,166
Total Value of Options$16,061,914
Total Number of Options329,075

Total Compensation*

Total Annual Cash Compensation$2,954,219
Total Short Term Compensation$887,000
Other Long Term Compensation$3,409,826
Total Calculated Compensation$7,029,873
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $194.16 USD +1.06


Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
Olivier Bohuon Chief Executive Officer, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination & Governance Committee
Smith & Nephew plc
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
Lars Rasmussen B.Sc (Eng), MBAChief Executive Officer and President
Coloplast A/S
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at